Gary Remington

26.2k total citations · 4 hit papers
468 papers, 17.8k citations indexed

About

Gary Remington is a scholar working on Psychiatry and Mental health, Philosophy and Cellular and Molecular Neuroscience. According to data from OpenAlex, Gary Remington has authored 468 papers receiving a total of 17.8k indexed citations (citations by other indexed papers that have themselves been cited), including 323 papers in Psychiatry and Mental health, 86 papers in Philosophy and 80 papers in Cellular and Molecular Neuroscience. Recurrent topics in Gary Remington's work include Schizophrenia research and treatment (299 papers), Mental Health and Psychiatry (86 papers) and Bipolar Disorder and Treatment (75 papers). Gary Remington is often cited by papers focused on Schizophrenia research and treatment (299 papers), Mental Health and Psychiatry (86 papers) and Bipolar Disorder and Treatment (75 papers). Gary Remington collaborates with scholars based in Canada, Japan and United States. Gary Remington's co-authors include Shitij Kapur, George Foussias, Ofer Agid, Gagan Fervaha, Robert B. Zipursky, Sylvain Houle, Tony Cohn, Hiroyoshi Takeuchi, Ariel Graff‐Guerrero and Guy Faulkner and has published in prestigious journals such as Neuron, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Gary Remington

458 papers receiving 17.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Relationship Between Dopamine D₂ Occupancy, Clinical Response, and Side Effects: A Double-Blind PET Study of First-Episode Schizophrenia

2000 808 citations Gary Remington et al. profile →
A Canadian Multicenter Placebo-Controlled Study of Fixed Doses of Risperidone and Haloperidol in the Treatment of Chronic Schizophrenic Patients

1993 704 citations Gary Remington et al. Journal of Clinical Psychopharmacology profile →
Negative Symptoms in Schizophrenia: Avolition and Occam's Razor

2008 457 citations George Foussias, Gary Remington profile →
Guidelines for the Pharmacotherapy of Schizophrenia in Adults

2017 213 citations Gary Remington, Zahinoor Ismail et al. The Canadian Journal of Psychiatry profile →

Peers

Countries citing papers authored by Gary Remington

Since Specialization

Citations

This map shows the geographic impact of Gary Remington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Remington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Remington more than expected).

Fields of papers citing papers by Gary Remington

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Remington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Remington. The network helps show where Gary Remington may publish in the future.

Co-authorship network of co-authors of Gary Remington

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Remington. A scholar is included among the top collaborators of Gary Remington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Remington. Gary Remington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impaired insight in schizophrenia is associated with higher frontoparietal cerebral blood flow: an arterial spin labeling study 2025 ·Schizophrenia ·(unknown), (unknown), (unknown), Sofia Chavez, Fumihiko Ueno, (unknown), (unknown), (unknown), Vincenzo De Luca, Daniel M. Blumberger, Gary Remington, Bruce G. Pollock, Ariel Graff‐Guerrero, Philip Gerretsen	1
2	Assessing past suicidal behaviour in schizophrenia spectrum disorders using the Columbia-Suicide Severity Rating Scale and the Beck Scale for Suicide Ideation: Analysis across the life-span 2024 ·Schizophrenia Research ·(unknown), (unknown), Philip Gerretsen, Corinne E. Fischer, Ariel Graff, Carol Borlido, Gary Remington, Vincenzo De Luca	0
3	Clinical improvement in schizophrenia during antipsychotic treatment in relation to changes in glucose parameters: A systematic review 2023 ·Psychiatry Research ·(unknown), (unknown), Susana Pereira, Eesha Sharma, Ganesan Venkatasubramanian, Gary Remington, Sri Mahavir Agarwal, Margaret Hahn	2
4	The metabolic adverse effects of antipsychotic use in individuals with intellectual and/or developmental disability: A systematic review and meta‐analysis 2022 ·Acta Psychiatrica Scandinavica ·Emily R. Smith, Nicolette Stogios, (unknown), (unknown), (unknown), (unknown), Mikkel Sørensen, (unknown), Hsiang‐Yuan Lin, Pushpal Desarkar, Yona Lunsky, Gary Remington, Margaret Hahn, Sri Mahavir Agarwal	8
5	Metformin for the prevention of clozapine‐induced weight gain: A retrospective naturalistic cohort study 2022 ·Acta Psychiatrica Scandinavica ·Nicolette Stogios, (unknown), (unknown), Marcos Sanches, Valerie Powell, Philip Gerretsen, Ariel Graff‐Guerrero, Araba Chintoh, George Foussias, Gary Remington, Margaret Hahn, Sri Mahavir Agarwal	14
6	Behavioural phenotypes of intrinsic motivation in schizophrenia determined by cluster analysis of objectively quantified real-world performance 2022 ·Schizophrenia ·Ishraq Siddiqui, Gary Remington, (unknown), (unknown), Paul Fletcher, Aristotle N. Voineskos, Konstantine K. Zakzanis, George Foussias	1
7	Adiposity in schizophrenia: A systematic review and meta‐analysis 2021 ·Acta Psychiatrica Scandinavica ·Emily R. Smith, Raghunath Singh, (unknown), (unknown), Ariel Graff‐Guerrero, Gary Remington, Margaret Hahn, Sri Mahavir Agarwal	20
8	Real-World Utilization Patterns of Long-Acting Injectable Antipsychotics in Canada: A Retrospective Study 2021 ·The Canadian Journal of Psychiatry ·Ofer Agid, Gary Remington, (unknown), (unknown), (unknown), G Anger	9
9	Glutathione Levels and Glutathione-Glutamate Correlation in Patients With Treatment-Resistant Schizophrenia 2021 ·Schizophrenia Bulletin Open ·Yusuke Iwata, Shinichiro Nakajima, Eric Plitman, Peter Truong, Ali Bani‐Fatemi, Fernando Caravaggio, Julia Kim, Parita Shah, Wanna Mar, Sofia Chavez, Gary Remington, Philip Gerretsen, Vincenzo De Luca, Napapon Sailasuta, Ariel Graff‐Guerrero	22
10	Adherence to clozapine vs. other antipsychotics in schizophrenia 2020 ·Acta Psychiatrica Scandinavica ·Hiroyoshi Takeuchi, Carol Borlido, Marcos Sanches, Celine Teo, (unknown), Ofer Agid, Gary Remington	25
11	Reward-driven decision-making impairments in schizophrenia 2018 ·Schizophrenia Research ·(unknown), (unknown), Ishraq Siddiqui, Ofer Agid, Zafiris J. Daskalakis, Arun Ravindran, Aristotle N. Voineskos, Konstantine K. Zakzanis, Gary Remington, George Foussias	29
12	The Effect of Clozapine on Hematological Indices 2015 ·Journal of Clinical Psychopharmacology ·Jimmy Lee, Hiroyoshi Takeuchi, Gagan Fervaha, Valerie Powell, (unknown), Robert R. Bies, Gary Remington	37
13	Estimated Dopamine D2 Receptor Occupancy and Remission in Schizophrenia 2013 ·Journal of Clinical Psychopharmacology ·Sho Moriguchi, Robert R. Bies, Gary Remington, Takefumi Suzuki, David C. Mamo, Koichiro Watanabe, Masaru Mimura, Bruce G. Pollock, Hiroyuki Uchida	21
14	Acute Effects of Single-Dose Olanzapine on Metabolic, Endocrine, and Inflammatory Markers in Healthy Controls 2013 ·Journal of Clinical Psychopharmacology ·Margaret Hahn, (unknown), Tamara Arenovich, Celine Teo, Adria Giacca, Valerie Powell, (unknown), Paul Fletcher, Tony Cohn, Roger S. McIntyre, (unknown), Araba Chintoh, Gary Remington	68
15	Clozapine and Global Cognition in Schizophrenia 2010 ·Journal of Clinical Psychopharmacology ·Tarek K. Rajji, Hiroyuki Uchida, Zahinoor Ismail, (unknown), David C. Mamo, Gary Remington, Bruce G. Pollock, Benoit H. Mulsant	35
16	Long-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse prevention 2010 ·Expert Opinion on Pharmacotherapy ·Ofer Agid, George Foussias, Gary Remington	66
17	Clozapine Exposure and the Impact of Smoking and Gender: A Population Pharmacokinetic Study 2009 ·Therapeutic Drug Monitoring ·(unknown), Hiroyuki Uchida, Zahinoor Ismail, David C. Mamo, Tarek K. Rajji, Gary Remington, Beth Sproule, Bruce G. Pollock, Benoit H. Mulsant, Robert R. Bies	50
18	Brain mechanisms and psychotropic drugs 1996 ·CRC Press eBooks ·Andrius Baskys, Gary Remington	15
19	The Effect of Psychopathology on the Ability of Schizophrenic Patients to Give Informed Consent 1994 ·The Journal of Nervous and Mental Disease ·(unknown), Irwin Kleinman, Peter Prendergast, Gary Remington, (unknown)	35
20	Coadministration of a beta-adrenergic antagonist and a tricyclic antidepressant: A pilot study 1990 ·Psychiatry Research ·Siu Wa Tang, Gary Remington, Emmanuel Persad, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact